Nedocromil

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Antiallergic, mast cell stabilizer.

Half-lifeThis section has been translated automatically.

2–3 h

IndicationThis section has been translated automatically.

Asthma prophylaxis, allergic rhinitis. S.a. disodium cromoglicic acid.

Limited indicationThis section has been translated automatically.

Pregnancy 1st trimester, children < 12 years.

Dosage and method of useThis section has been translated automatically.

  • Asthma prophylaxis: Initial 2-4 times 2 sprays/day per inhalation, if the response is good the dosage is gradually reduced to 2 times/day 2 strokes.
  • Rhinitis allergica: 4 times/day 1 spray in each nostril.
  • allergic rhinoconjunctivitis: 2 times/day 1 drop.

Standard concentrationThis section has been translated automatically.

1% as a spray.

InteractionsThis section has been translated automatically.

Interactions with Nedocromil are not known.

ContraindicationThis section has been translated automatically.

Hypersensitivity to active ingredients and auxiliary materials.

PreparationsThis section has been translated automatically.

Tilade, Irtan

LiteratureThis section has been translated automatically.

  1. Sennekamp J et al (2002) German Society for Allergology and Clinical Immunology (DGAI) and Medical Association of German Allergologists (ÄDA) AWMF Guidelines Register No. 061/013

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer